Literature DB >> 8210709

The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection.

L Bertolini1, S Iacovacci, A Ponzetto, G Gorini, M Battaglia, G Carloni.   

Abstract

The euploid-diploid cell line CE, issuing spontaneously from a normal human bone marrow culture, displays B-cell differentiation and activation markers and is positive (> or = 90% of cells) for Epstein-Barr nuclear antigens. CE suspensions were inoculated with serum from a patient chronically infected with hepatitis C virus (HCV). After inoculation, the cells were regularly subcultured with a split ratio of 1:2 every 4-6 days. RNA extracted as late as 65 days after infection from the inoculated cells were positive by polymerase chain reaction for the 5' untranslated region of the HCV genome, and viral antigens were detected by immunofluorescence. Virus was also released from the infected cells into the medium. Intracellular HCV could be successfully passaged twice in CE cultures. On the basis of these findings, the CE cell line appears promising as a model for studying HCV replication and persistent infection in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8210709     DOI: 10.1016/s0923-2516(06)80041-5

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  9 in total

1.  Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees.

Authors:  Y K Shimizu; H Igarashi; T Kanematu; K Fujiwara; D C Wong; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Hepatitis C virus in human B lymphocytes transformed by Epstein-Barr virus in vitro by in situ reverse transcriptase-polymerase chain reaction.

Authors:  J L Cheng; B L Liu; Y Zhang; W B Tong; Z Yan; B F Feng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

4.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.

Authors:  N Sakamoto; C H Wu; G Y Wu
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

6.  Characterization of long-term cultures of hepatitis C virus.

Authors:  N Nakajima; M Hijikata; H Yoshikura; Y K Shimizu
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak.

Authors:  M Höhne; E Schreier; M Roggendorf
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell lines.

Authors:  Rafael Marino; Leopoldo Deibis; Juan B De Sanctis; Nicolas E Bianco; Felix Toro
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

9.  A vaccinia replication system for producing recombinant hepatitis C virus.

Authors:  Ying-Song Wu; Yu Feng; Wen-Qi Dong; Yan-Ming Zhang; Ming Li
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.